Suppr超能文献

人绒毛膜促性腺激素与甲状腺:妊娠剧吐和滋养细胞肿瘤。

Human chorionic gonadotropin and the thyroid: hyperemesis gravidarum and trophoblastic tumors.

作者信息

Hershman J M

机构信息

Endocrinology Division, West Los Angeles VA Medical Center and UCLA School of Medicine, California 90073, USA.

出版信息

Thyroid. 1999 Jul;9(7):653-7. doi: 10.1089/thy.1999.9.653.

Abstract

There is abundant evidence that human chorionic gonadotropin (hCG) is a weak thyrotropin (TSH) agonist. In FRTL-5 rat thyroid cells, hCG increases cyclic adenosine monophosphate (cAMP), iodide transport, and cell growth. hCG has thyroid-stimulating activity in bioassays in mice and in clinical studies in man. In cultured cells transfected with the human TSH receptor, hCG increases generation of cAMP. Molecular variants of hCG with increased thyrotropic potency include basic molecules with reduced sialic acid content, truncated molecules lacking the C-terminal tail, or molecules in which the 47-48 peptide bond in the beta-subunit loop is nicked. In normal pregnancy, when hCG levels are highest at 10 to 12 weeks gestation, there is suppression of serum TSH levels, presumably due to slight increases in free thyroxine (T4) concentration. In twin pregnancies, hCG levels tend to be higher and suppressed TSH levels are more frequent. Hyperemesis gravidarum, defined as severe vomiting in early pregnancy that causes 5% weight loss and ketonuria, is usually associated with increased hCG concentration. A high proportion of patients with hyperemesis gravidarum, about one-third to two-thirds in different series, have evidence of increased thyroid function. Only a small proportion of these patients have clinical hyperthyroidism, termed gestational thyrotoxicosis. These patients probably secrete a variant of hCG with increased thyroid-stimulating activity. Trophoblastic tumors, hydatidiform mole, and choriocarcinoma often cause hyperthyroidism because they secrete very large amounts of hCG. When the serum hCG exceeds about 200 IU/mL, hyperthyroidism is likely to be found. There is a correlation between the biochemical severity of hyperthyroidism and the serum hCG in these patients. Removal of the mole or effective chemotherapy of the choriocarcinoma cures the hyperthyroidism. In conclusion, hCG has thyroid-stimulating activity that influences thyroid function early in pregnancy when hCG levels are high. Excessive hCG secretion may cause hyperthyroidism in patients with hyperemesis gravidarum or trophoblastic tumors.

摘要

有充分证据表明,人绒毛膜促性腺激素(hCG)是一种弱促甲状腺激素(TSH)激动剂。在FRTL - 5大鼠甲状腺细胞中,hCG可增加环磷腺苷(cAMP)、碘转运及细胞生长。hCG在小鼠生物测定及人体临床研究中具有甲状腺刺激活性。在转染了人TSH受体的培养细胞中,hCG可增加cAMP的生成。促甲状腺活性增强的hCG分子变体包括唾液酸含量降低的碱性分子、缺乏C末端尾巴的截短分子,或β亚基环中47 - 48肽键有切口的分子。在正常妊娠中,当hCG水平在妊娠10至12周时最高,血清TSH水平会受到抑制,这可能是由于游离甲状腺素(T4)浓度略有升高。在双胎妊娠中,hCG水平往往更高,TSH水平受抑制的情况更常见。妊娠剧吐定义为妊娠早期严重呕吐导致体重减轻5%及酮尿症,通常与hCG浓度升高有关。妊娠剧吐患者中很大一部分,不同系列报道约三分之一至三分之二,有甲状腺功能增强的证据。这些患者中只有一小部分有临床甲亢,称为妊娠甲状腺毒症。这些患者可能分泌了促甲状腺活性增强的hCG变体。滋养层细胞瘤、葡萄胎和绒毛膜癌常导致甲亢,因为它们分泌大量hCG。当血清hCG超过约200 IU/mL时,很可能会出现甲亢。这些患者甲亢的生化严重程度与血清hCG之间存在相关性。切除葡萄胎或对绒毛膜癌进行有效的化疗可治愈甲亢。总之,hCG具有甲状腺刺激活性,在妊娠早期hCG水平高时会影响甲状腺功能。hCG分泌过多可能导致妊娠剧吐患者或滋养层细胞瘤患者出现甲亢。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验